About
Telma LN tablets are a combination medication containing Telmisartan and Amlodipine, designed for the effective management of essential hypertension. Telmisartan is an angiotensin II receptor blocker (ARB) that works by selectively blocking the AT1 receptor, leading to vasodilation and a reduction in blood pressure without affecting heart rate. Amlodipine is a dihydropyridine calcium channel blocker (CCB) that causes peripheral vasodilation by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle, further lowering blood pressure.
This combination provides a synergistic effect, offering potent and sustained blood pressure reduction, which is particularly beneficial for patients whose blood pressure is not adequately controlled by monotherapy. By targeting different pathways involved in blood pressure regulation, Telma LN helps to reduce the risk of cardiovascular events such as stroke and heart attack, improving overall cardiovascular outcomes. It is generally well-tolerated and offers 24-hour blood pressure control.
Uses
- Treatment of essential hypertension.
- Management of hypertension when monotherapy is insufficient.
- Reduction of cardiovascular risk in hypertensive patients.
- Long-term blood pressure control.
Directions For Use
Take one tablet orally once daily, with or without food, as directed by your physician.
Benefits
- Potent and sustained blood pressure reduction.
- Provides 24-hour blood pressure control.
- Reduces the risk of cardiovascular events.
- Improves patient compliance with a single tablet.
- Dual mechanism of action for comprehensive control.
- Generally well-tolerated.
Side Effects
- Dizziness
- Headache
- Peripheral edema (swelling of ankles/feet)
- Fatigue
- Flushing
- Palpitations
- Nausea
- Abdominal pain
- Hyperkalemia (due to Telmisartan)
- Hypotension
- Cough (less common than ACE inhibitors)
- Muscle cramps
Safety Measures
- Alcohol - Alcohol may enhance the hypotensive effects of Telma LN, leading to increased dizziness or lightheadedness. Limit alcohol intake.
- Pregnancy - Telmisartan is contraindicated during pregnancy, especially in the second and third trimesters, due to potential fetal harm.
- Breastfeeding - Not recommended during breastfeeding due to the Telmisartan component, which may pass into breast milk. Consult your doctor.
- Liver - Use with caution in patients with liver impairment. Dose adjustment may be needed, especially for Telmisartan, and liver function should be monitored.
- Kidney - Use with caution in patients with renal impairment. Monitor kidney function regularly, and dose adjustment may be required.
- Lung - Generally considered safe for patients with lung conditions.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!